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Abstract Cathepsin E is a homodimer, consisting of two mono- 
mers linked by an inter-molecular disulphide bond. The cysteine 
residue involved is located near to the N-terminus of the mature 
proteinase. By mutating this residue to alanine, a monomeric 
form of human cathepsin E was engineered and purified. The 
activity of the resultant enzyme was not altered significantly (in 
terms of its ability to hydrolyse two chromogenic peptide sub- 
strates; and its susceptibility to inhibition by pepstatin). However, 
the stability of the mutant enzyme to alkaline pH and to temper- 
ature was markedly reduced. 
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1. Introduction 
Aspartic proteinases have been isolated and studied from a 
wide variety of organisms, varying from vertebrates to plants, 
fungi, parasites and retroviruses [1]. Of the five known to be 
present in the human body, three (pepsin, gastricsin and renin) 
are secretory enzymes while one (cathepsin D) is located within 
the lysosomes. The fifth proteinase, cathepsin E is neither a 
secretory enzyme nor is it located in the lysosomes. The crystal 
structures that have been determined for pepsin [2], renin [3] 
and cathepsin D [4] indicate that these enzymes are closely 
similar not just to each other but also to aspartic proteinases 
of vertebrate/fungal or parasitic origin. In their mature forms, 
these non-viral aspartic proteinases have M r = ~40K and are 
(commonly) single polypeptide chains. In this regard too, 
cathepsin E is distinct since it has a molecular mass of~84 kDa. 
Located close to the N-terminus of the mature enzyme in the 
sequence Thr-Glu-Ser-Cys-Ser-, cathepsin E has a unique cyste- 
ine residue that is not present in any other aspartic proteinase 
[1]. It has been postulated that by formation of an intermolecu- 
lar-disulphide bond, this residue brings about dimerisation of 
two identical 42 kDa subunits to give rise to the ~84 kDa form 
of the mature enzyme. In this report, it is established for the 
first time unequivocally that this is indeed the case and the 
significance of this unique cysteine residue is investigated 
in terms of its influence on the activity and stability of 
cathepsin E. 
2. Materials and methods 
Cathepsin E was obtained from human tissues as described previ- 
ously [5] and is referred to as naturally-occurring enzyme in the text. 
*Corresponding author. Fax: (44) (1222) 87-4116. 
The cDNA encoding human procathepsin E was generated as reported 
in [6]. Synthetic oligonucleotides were purchased from Genosys Bio- 
technologies Inc., Cambridge, UK. 
The Cys4-Ala mutation (and a convenient Nhel restriction site) were 
introduced by overlapping PCR using the 5'-forward 
(5' AG GAA TTC CAT ATG GGA TCC CTT CAC AGG 3' 
Primer 1) 
and 3'-reverse 
(5' CCC AGA TCT TTA GGG GAC TGC TGG GGC 3' - Primer 
2) 
oligonucleotides a primers and the complementary pair of primers 
(5' GTC CAT GCT AGC GGA CTC GGT GAA CTG GAT 3' - 
Primer 3) 
5' GAG TCC GCT AGC ATG GAC CAG AGT GCC AAG 3' 
Primer 4. 
DNA amplifications were performed using 20 ng of the cDNA en- 
coding procathepsin E [7], 2 units of Vent DNA polymerase (New 
England Biolabs, Beverly, MA, USA), 2 mM MgSO4, 1 mM of each 
primer and 10 mM dNTPs in a final volume of 100 ml. Amplification 
was achieved by using a Biometra Trio (Maidstone, Kent, UK) pro- 
grammable thermoblock. An initial denaturation step of 94°C for 3 min 
was followed by 20 cycles of: 94°C for 1 min, 58°C for 1 rain and 72°C 
for 1.5 min, after which a final elongation step of 72°C for 5 rain was 
performed. 
Amplifications involving the primer combinations 1 with 3 and 2 with 
4 resulted in the generation of two products of approximately 150 and 
1000 bp, respectively, which were each cloned into pUC18 using the 
Sureclone Ligation Kit (Pharmacia Biotech. Ltd., Milton Keynes, UK). 
Authentication f the nucleotide sequence of both cloned products was 
achieved by dideoxy sequencing using a Pharmacia ALF automated 
sequencer. The 150 and 1000 bp fragments were subsequently excised 
from pUC18 and via a 3-way ligation reaction were sub-cloned into the 
NdeI/BamHI sites of the T7-expression vector pET16b (AMS Biotech. 
Ltd., Witney, Oxon, UK). Positive recombinant molecules containing 
the unique NheI restriction site were sequenced toconfirm the continu- 
ity of the procathepsin E open reading frame with respect o the initia- 
tion methionine residue provided by the expression vector 
pET 16b. 
Expression of the Cys4-Ala procathepsin E mutant was carried out 
in E. coli BL21(DE3) pLysS as described previously for wild-type pro- 
tein [6] except for the following modifications which increased the final 
yield of purified (mutant) enzyme by approximately 4-fold. All induc- 
tions were initiated by the addition of 1 mM IPTG. The initial lysed 
cell debris was subjected to an additional wash of 100 mM Tris-HCl, 
pH 11.0, supplemented with 50 mM mercaptoethanol prior to the 
solubilisation step with 6 M urea. Renaturation of the solubilised mate- 
rial was achieved by a 200-fold dilution of the denaturant in 10 mM 
Tris-HCl buffer, pH 9.5, and the resultant solution was re-concentrated 
using a Filtron Ultrasette, 5 kDa cut-off, tangential flow concentrator 
(Flowgen Instruments Ltd., Sittingbourne, Kent, UK). 
Analyses of samples by SDS-PAGE and Western blotting and prote- 
olytic activity measurements against haemoglobin as a substrate were 
carried out as described in [5,6], as was N-terminal sequence analysis 
by Edman degradation and determination of kinetic parameters for 
chromogenic peptide substrate hydrolysis and inhibitor binding. 
Measurements of proteinase stability were made by incubating sam- 
ples of the mutant or naturally-occurring enzymes at different temper- 
atures in buffers of a variety ofpH values (Tris, pH 7.5 and 8.5; CAPS, 
pH 9.5 and 10.5). All were used at a final ionic strength of 0.1 M. At 
appropriate times, aliquots were removed and residual activity was 
measured at pH 3.1 using the chromogenic substrate Lys-Pro-lle-Glu- 
Phe*Nph-Arg-Leu as described [5,6]. The influence of glycerol was also 
assessed by its inclusion in the different pH incubation buffers. 
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3. Results and discussion 
Following mutation of the cDNA encoding procathepsin E,
the presence of the alteration in the clone was verified by dide- 
oxy sequencing in both strands. Subsequently, the Cys4-Ala 
mutant DNA was manipulated into the expression plasmid 
pET-16b. The recombinant plasmid was transformed into E. 
coli and induced with IPTG. After 2 h, the cells were harvested, 
lysed and the mutant zymogen was extracted with urea and 
re-folded by rapid dilution at pH 9.5, as described in section 2. 
After concentration, the pH of the resultant protein solution 
was adjusted to 3.1 and the mixture was incubated for 1 h at 
37°C. Following centrifugation, the supernatant was neutral- 
ised, centrifuged again and aliquots were analysed by SDS- 
PAGE (Fig. 1). A single band of protein was observed with mol. 
wt. close to 40K under both reducing (Fig. 1, Lane 2) and 
non-reducing (Lane 4) conditions. In contrast, analysis of wild- 
type cathepsin E under the same conditions revealed that, 
whereas the protein did migrate as a monomeric species in the 
presence of reducing agent (Fig. 1, Lane 1), when the SDS- 
PAGE was performed in the absence of EtSH most of the 
protein was present in the dimeric form of approximately 84 
kDa (Fig. 1. Lane 3). Naturally-occurring (pro)cathepsin 
E contains one -Asn-X-Thr motif [7,8] and is thus a glycopro- 
tein as isolated from human tissues. The influence of the carbo- 
hydrate on mobility is evident on SDS-PAGE under reducing 
conditions, since the monomeric naturally-occurring enzyme 
(Lane 1) migrated with a slightly higher tool. wt. than that of 
the recombinant mutant produced in E. coli (Lane 2). 
The mutant enzyme thus produced was subjected to 20 cycles 
of Edman degradation. This confirmed that mature enzyme 
had been generated by (complete) autoactivation of the re- 
folded zymogen during the incubation at pH 3.1 (see above). 
However, a unique sequence was not observed; rather three 
overlapping sequences were elucidated, and were present in the 
approximate ratios of 2 : 1 : 1. These were: 
TE SASMDQ SAKE PL  INYLD~ 
S A S M D Q S A K E  PL  INYLD~ 
DQ SAKE PL  INYLD~ 
This microheterogeneity at the N-terminus of the mutant 
enzyme is in contrast o the situation observed with recombi- 
nant wild-type cathepsin E where a unique sequence of TESC- 
was determined [6]. Thus, it would appear that the presence of 
cysteine-4 and its ability to bring about dimerisation through 
97 -+  
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43 --> 
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Fig. 1. SDS-PAGE of samples containing cathepsin E. Samples (con- 
taining approx. 1 mg of protein) were analysed under educing condi- 
tions (in the presence of 50 mM mercaptoethanol) f r Lanes 1 and 2 
or in the absence of reducing agent (Lanes 3 and 4). Naturally-occurring 
human cathepsin E was loaded in Lanes 1 and 3 while the CystAla 
mutant enzyme was applied in Lanes 2 and 4. Staining was with 
Coomassie blue and tool. wt. markers (kDa) migrated as indicated. 
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Fig. 2. Influence of reducing agent on the substrate dependence for 
hydrolysis by naturally-occurring cathepsin E. Measurements of initial 
velocity (pmol/s x 10 -2) were made at differing concentrations of sub- 
strate in the absence (1) and presence (©) of reducing agent. In (a) the 
substrate was Lys-Pro-Ile-Glu-Phe*Nph-Arg-Leu, pH was 3.1 and di- 
thiothreitol (20 mM) was the reducing agent; in (b) the substrate was 
Pro-Pro-Thr-Ile-Phe*Nph-Arg-Leu, the pH was 5.8, 6.25 mM ATP [15] 
was included in all assays and mercaptoethanol (50 mM) was the reduc- 
ing agent. 
disulphide bond formation has an influence on the process of 
autoactivation, restricting the autolytic leavage to bond(s) up- 
stream from the disulphide bond. In this regard, the naturally- 
occurring mature form of human cathepsin E is noticeably 
longer (by -8  residues) than other aspartic proteinases ofverte- 
brate and fungal origin [6,8,9]. However, when the cysteine is 
no longer present (replaced by Ala in the mutant), the autoac- 
tivation processes by which zymogens of aspartic proteinases 
are progressively diminished in size from the N-terminal end 
until the mature nzyme is produced [9], are apparently able to 
proceed further to produce protein species that are shorter in 
length at their N-terminal end and are thus more akin in size 
to other aspartic proteinases, e.g. pepsin and cathepsin D. 
To date, (full-length gene) sequences have been elucidated 
for cathepsin E of human [7], guinea pig [10], rabbit [8] and rat 
[11] origin and a partial protein sequence has been determined 
for monkey cathepsin E (B.M.D., J.K., S. Rapundalo and B. 
Batley, unpublished observations). 
Human: T E S C S ~ 
Monkey:  T E S C S ~ 
Rabbit: T E T C T ~ 
Guinea pig: - - - C S ~ 
Rat: s E S C N ~ 
In all cases, the cysteine (at residue 4) in the sequence is 
conserved and the enzymes exist in the tissues of their respective 
species predominantly in dimeric form. In order to determine 
whether the presence of the interchain disulphide link is impor- 
tant for activity, the ability of the Cys4-Ala mutant cathepsin 
E to hydrolyse two synthetic substrates was examined. The 
kinetic parameters obtained (Table 1) for each of the two sub- 
strates were not substantially different from those reported 
previously for the hydrolysis of these chromogenic peptides by 
recombinant wild-type [6] and naturally-occurring [5]human 
cathepsin E. For example, the corresponding kcat/Km values 
measured for the two substrates with wild-type recombinant 
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Table 1 
Kinetic constants for the hydrolysis of chromogenic substrates by the 
Cysa-Ala mutant cathepsin E
Km k., k.,/Km 
(BM) (s-l) (toM-1 .s l) 
Pro-Pro-Thr-Ile-Phe*Nph-Arg-Leu 45 70 1,550 
Lys-Pro-Ile-Glu-Phe*Nph-Arg-Leu 40 82 2,050 
Measurements were made in 0.1 M sodium formate buffer, pH 3.1, at 
37°C. The estimated precision of the values obtained was in the range 
10-15%. 
enzyme were 2,300 and 1,850 mM -~'s -~ [6] compared to the 
values of 1,550 and 2,050 mM -1- s -1 determined for the mutant 
(Table 1). Furthermore, the Cysn-Ala mutant of cathepsin E
was just as susceptible (K~ < 0.1 nM) to inhibition by pepstatin 
as its wild-type recombinant and naturally-occurring counter- 
parts. In further substantiation f this, the influence of reducing 
agent on the hydrolysis of the two chromogenic substrates by 
naturally-occurring human cathepsin E was examined (Fig. 2). 
The shape of each of the o versus [s] curves, measured at pH 
3.1 in one case (Fig. 2a) and at pH 5.8 in the other (Fig. 2b), 
was indistinguishable from the substrate dependence observed 
in the presence of reducing agent (dithiothreitol in Fig. 2a; 
mercaptoethanol in Fig. 2b). On these bases, it would appear 
that the activity ofcathepsin E is not dependent on the presence 
of the interchain disulphide bond. 
Some aspartic proteinases such as pepsin are not stable in 
alkaline pH and it has been shown that this results from a 
selective denaturation of the N-terminal domain [12]. Conse- 
quently, the stability of the Cysn-Ala mutant cathepsin E to 
temperature and alkaline pH was evaluated. At 25°C and 
below, the mutant was stable (t~/2 >> 3 h) at pH values as high 
as pH 9.5 so that, for affinity purification purposes, cathepsin 
E can be recovered from pepstatin-agarose columns by desorp- 
tion at pH values up to 9.5. When the temperature was elevated 
to 37°C, the mutant was still stable at pH 8.5 (t~/2 ~ 16 h) but at 
pH 9.5, a half-life of 40 min was measured and at pH 10.5, the 
mutant enzyme was inactivated very rapidly (t112 - 3 min). On 
this basis, the temperature d pendence was assessed at pH 8.5. 
Although the enzyme was stable at 37°C, a half-life of 40 min 
was measured at 45°C and further elevation to 55°C resulted 
in a rapid inactivation (t,2 < 5 min). This sensitivity to 55°C 
was used to compare the stabilities of the monomeric Cys4-Ala 
mutant cathepsin E and the dimeric wild-type form of the 
enzyme. At pH 7.5 and 55°C, the dimeric enzyme had a half-life 
of 35 rain. In contrast, the Cys4-Ala mutant was very unstable, 
with a half-life of only 1.7 min, measured both in the absence 
and in the presence of glycerol (2.5% final concentration). (The 
influence of glycerol was examined because for long-term stor- 
age of cathepsin E, which is inactivated upon freezing [13], the 
enzyme is commonly kept at -20°C in 50% glycerol in order 
to prevent solidification). Thus, it would appear that the pres- 
ence of the inter-chain disulphide bond in cathepsin E confers 
stability on the dimeric enzyme that is lost in the Cysa-Ala 
mutant. These data which provide the first direct evidence for 
this conclusion, are in keeping with earlier findings with natu- 
rally-occurring guinea pig cathepsin E [8]. In that report, it was 
shown that when mercaptoethanol was present in the incuba- 
tion buffer, monomeric athepsin E had a half-life of approxi- 
mately 2 h at pH 7.5 and 28°C whereas dimeric enzyme was 
essentially stable. 
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While this manuscript was nearing completion, Finley and 
Kornfeld [14] described their construction of a variety of 
chimaeric DNAs in which regions of human procathepsin E 
were systematically replaced with the counterpart sequences 
from pepsinogen (which is a secretory zymogen). These elegant 
experiments revealed that the region of (pro)cathepsin E that 
specifies retention of this protein within the endosomal/e.r. 
network is indeed the sequence of residues in which cysteine-4 
is located [14]. It would appear then that for its activity and 
fulfilment of its physiological roles in that capacity, cathepsin 
E does not need to exist as a disulphide-linked homodimer. 
However, since the enzyme is not, unlike pepsin, directed ex- 
tracellularly into a very acidic environment, nor trafficked into 
an acidic lysosomal organelle (as is cathepsin D) but rather is 
retained within a cellular compartment that is at neutral or only 
slightly acidic pH, it would seem that the device of introducing 
an interchain disulphide bond at the N-terminus of the mole- 
cule not only confers tability upon the protein but also ensures 
that it is retained within the appropriate cytomorphological 
compartment of the cell. Structural studies by X-ray crystallo- 
graphic analysis of the wild-type and Cys4-Ala mutant enzymes 
should provide a valuable insight into the importance of this 
highly-conserved cysteine residue in a unique region of this 
aspartic proteinase. 
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